Age-related brain parenchymal fraction is significantly decreased in young multiple sclerosis patients: a quantitative MRI study

被引:34
作者
Kassubek, J
Tumani, H
Ecker, D
Kurt, A
Ludolph, AC
Juengling, FD
机构
[1] Univ Ulm, Dept Neurol, D-89081 Ulm, Germany
[2] Univ Ulm, Dept Nucl Med, D-89081 Ulm, Germany
关键词
ageing; brain atrophy; brain parenchymal fraction; magnetic resonance imaging; multiple sclerosis;
D O I
10.1097/01.wnr.0000058960.85541.17
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The extent of brain atrophy was determined in 33 patients with multiple sclerosis (MS) and in 60 healthy subjects (21-76 years) by calculating brain parenchymal fractions (BPF, the ratio of brain parenchymal to intracranial volume) from 3D MRI. Within the normal data base, subjects at higher ages showed significantly lower BPF values. In younger MS patients, BPF was significantly decreased compared with age-matched controls (20-29 years, p = 0.0022; 30-39 years, p = 0.0001; 40-49 years, p = 0.0444) and was significantly correlated with disease duration and disease severity, but not with the number of detectable MS lesions. Determination of age-related BPF demonstrated significant brain atrophy in early MS and can be considered as a useful biological marker for monitoring MS.
引用
收藏
页码:427 / 430
页数:4
相关论文
共 24 条
[1]   Voxel-based morphometry - The methods [J].
Ashburner, J ;
Friston, KJ .
NEUROIMAGE, 2000, 11 (06) :805-821
[2]   Regional brain atrophy is associated with physical disability in multiple sclerosis: Semiquantitative magnetic resonance imaging and relationship to clinical findings [J].
Bakshi, R ;
Benedict, RHB ;
Bermel, RA ;
Jacobs, L .
JOURNAL OF NEUROIMAGING, 2001, 11 (02) :129-136
[3]   The reproducibility and sensitivity of brain tissue volume measurements derived from an SPM-based segmentation methodology [J].
Chard, DT ;
Parker, GJM ;
Griffin, CMB ;
Thompson, AJ ;
Miller, DH .
JOURNAL OF MAGNETIC RESONANCE IMAGING, 2002, 15 (03) :259-267
[4]   Brain atrophy in clinically early relapsing-remitting multiple sclerosis [J].
Chard, DT ;
Griffin, CM ;
Parker, GJM ;
Kapoor, R ;
Thompson, AJ ;
Miller, DH .
BRAIN, 2002, 125 :327-337
[5]   MR correlates of cerebral atrophy in patients with multiple sclerosis [J].
De Stefano, N ;
Iannucci, G ;
Sormani, MP ;
Guidi, L ;
Bartolozzi, ML ;
Comi, G ;
Federico, A ;
Filippi, M .
JOURNAL OF NEUROLOGY, 2002, 249 (08) :1072-1077
[6]   Magnetic resonance imaging of multiple sclerosis [J].
Filippi, M ;
Tortorella, C ;
Rovaris, M .
JOURNAL OF NEUROIMAGING, 2002, 12 (04) :289-301
[7]   Relationship between brain atrophy and disability: an 8-year follow-up study of multiple sclerosis patients [J].
Fisher, E ;
Rudick, RA ;
Cutter, G ;
Baier, M ;
Miller, D ;
Weinstock-Guttman, B ;
Mass, MK ;
Dougherty, DS ;
Simonian, NA .
MULTIPLE SCLEROSIS, 2000, 6 (06) :373-377
[8]   Progressive cerebral atrophy in MS - A serial study using registered, volumetric MRI [J].
Fox, NC ;
Jenkins, R ;
Leary, SM ;
Stevenson, VL ;
Losseff, NA ;
Crum, WR ;
Harvey, RJ ;
Rossor, MN ;
Miller, DH ;
Thompson, AJ .
NEUROLOGY, 2000, 54 (04) :807-812
[9]  
Friston K., 1995, HUM BRAIN MAP, V2, P165, DOI DOI 10.1002/HBM.460030303
[10]   Glatiramer acetate (Copaxone) treatment in relapsing-remitting MS - Quantitative MR assessment [J].
Ge, Y ;
Grossman, RI ;
Udupa, JK ;
Fulton, J ;
Constantinescu, CS ;
Gonzales-Scarano, F ;
Babb, JS ;
Mannon, LJ ;
Kolson, DL ;
Cohen, JA .
NEUROLOGY, 2000, 54 (04) :813-817